Technical Aspects of Focal Therapy in Localized Prostate Cancer
Focal therapy is a promising option for selected patients who have localized low or intermediate-risk prostate cancer, providing a compelling alternative between active surveillance and radical therapies by targeting the index lesion and preserving as muc
- PDF / 9,621,400 Bytes
- 252 Pages / 439.43 x 683.15 pts Page_size
- 61 Downloads / 181 Views
123
Technical Aspects of Focal Therapy in Localized Prostate Cancer
Eric Barret • Matthieu Durand Editors
Technical Aspects of Focal Therapy in Localized Prostate Cancer
Editors Eric Barret Department of Urology Institut Montsouris Paris-Descartes University Paris France
Matthieu Durand Department of Urology Hôpital Pasteur 2 Centre Hospitalier Universitaire de Nice University of Nice-Sophia-Antipolis Nice France
ISBN 978-2-8178-0483-5 ISBN 978-2-8178-0484-2 DOI 10.1007/978-2-8178-0484-2 Springer Paris Heidelberg New York Dordrecht London
(eBook)
Library of Congress Control Number: 2015930007 © Springer-Verlag France 2015 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. Exempted from this legal reservation are brief excerpts in connection with reviews or scholarly analysis or material supplied specifically for the purpose of being entered and executed on a computer system, for exclusive use by the purchaser of the work. Duplication of this publication or parts thereof is permitted only under the provisions of the Copyright Law of the Publisher’s location, in its current version, and permission for use must always be obtained from Springer. Permissions for use may be obtained through RightsLink at the Copyright Clearance Center. Violations are liable to prosecution under the respective Copyright Law. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. While the advice and information in this book are believed to be true and accurate at the date of publication, neither the authors nor the editors nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein. Printed on acid-free paper Springer is part of Springer Science+Business Media (www.springer.com)
Foreword
Paradigm Shift A critical change in how localized prostate cancer is managed is likely to take place due to the emerging combination of both new imaging modalities and novel accurate ablative therapies that are aimed at eradicating the controversial index lesion and that radically alter the ways to treat this disease. Nowadays, prostate cancer may be considered to be a chronic illness that can be treated, focally re-treated, and carefully followed up to control its evolution. With lower focal treatment-related morbidity, in addition to an ambitious dual goal of both organ-sparin
Data Loading...
